Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries:A Descriptive Analysis Alongside the Randomised Controlled ALIC(4)E Trial

Autor: Nick A Francis, Christopher C Butler, Philippe Beutels, Réka Mikó-Pauer, Ana García-Sangenís, Nikolaos Tsakountakis, Pär-Daniel Sundvall, Katarzyna Kosiek, Joke Bilcke, Rune Aabenhus, Emily Bongard, Ruta Radzeviciene Jurgute, Nicolay Jonassen Harbin, Samuel Coenen, Alike W van der Velden, Xiao Li, Bohumil Seifert, Pascale Bruno, Robin Bruyndonckx, Dominik Glinz

Publikováno v: Li, X, Bilcke, J, van der Velden, A W, Bongard, E, Bruyndonckx, R, Sundvall, P-D, Harbin, N J, Coenen, S, Francis, N, Bruno, P, Garcia-Sangenis, A, Glinz, D, Kosiek, K, Miko-Pauer, R, Radzeviciene Jurgute, R, Seifert, B, Tsakountakis, N, Aabenhus, R, Butler, C C & Beutels, P 2021, ' Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries : A Descriptive Analysis Alongside the Randomised Controlled ALIC(4)E Trial ', Clinical Drug Investigation, vol. 41, pp. 685–699 . https://doi.org/10.1007/s40261-021-01057-y
Clinical Drug Investigation
Clinical drug investigation

Background and Objective Influenza-like illness (ILI) leads to a substantial disease burden every winter in Europe; however, oseltamivir is not frequently prescribed to ILI patients in the primary-care setting. An open-label, multi-country, multi-sea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5373c91ce16eb40ed34701294b3678
https://curis.ku.dk/ws/files/276160160/Direct_and_Indirect_Costs_of_Influenza_Like_Illness_Treated_with_and_Without_Oseltamivir_in_15_European_Countries.pdf

Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC ⁴ E trial in 15 European countries.

Autor: Li X; Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Campus Drie Eiken, room D.S.221, Universiteitsplein 1, 2610, Antwerp, Belgium. xiao.li@uantwerpen.be., Bilcke J; Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Campus Drie Eiken, room D.S.221, Universiteitsplein 1, 2610, Antwerp, Belgium., van der Velden AW; Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands., Bruyndonckx R; Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), Data Science Institute (DSI), Hasselt University, Hasselt, Belgium.; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium., Coenen S; Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium., Bongard E; The Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., de Paor M; RCSI Department of General Practice, 123 St Stephens Green, Dublin 2, Ireland., Chlabicz S; Department of Family Medicine, Medical University of Bialystok, Białystok, Poland., Godycki-Cwirko M; Centre for Family and Community Medicine, Medical University of Lodz, Lodz, Poland., Francis N; School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK., Aabenhus R; Section and Research Unit of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Bucher HC; Division of Infectious Diseases and Hospital Hygiene, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland., Colliers A; Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium., De Sutter A; Department of Public Health and Primary Care (Centre for Family Medicine), Gent University, Gent, Belgium., Garcia-Sangenis A; University Institute in Primary Care Research Jordi Gol, Via Roma Health Centre, Barcelona, Spain., Glinz D; Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland., Harbin NJ; Department of General Practice, Antibiotic Center for Primary Care, Institute of Health and Society, University of Oslo, Oslo, Norway., Kosiek K; Family Doctors' Clinic, Lodz, Poland., Lindbæk M; Research Leader Antibiotic Centre for Primary Care, Department of General Practice, University of Oslo, Oslo, Norway., Lionis C; General Practice and Primary Health Care at the School of Medicine, University of Crete, Crete, Greece., Llor C; University Institute in Primary Care Research Jordi Gol, Via Roma Health Centre, Barcelona, Spain.; Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Mikó-Pauer R; DRC Drug Research Center LLC, Balatonfüred, Hungary., Radzeviciene Jurgute R; FDC Mano šeimos gydytojas, Klaipeda, Lithuania., Seifert B; Institute of General Practice, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic., Sundvall PD; General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Research, Education, Development and Innovation, Primary Health Care, Region Västra Götaland, Sandared, Sweden., Touboul Lundgren P; Département de Santé Publique, Hôpital de l'Archet, Nice, France., Tsakountakis N; Malia Surgery, Kastelli HC, Heraklio, Greece., Verheij TJ; Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands., Goossens H; Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium., Butler CC; The Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Beutels P; Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Campus Drie Eiken, room D.S.221, Universiteitsplein 1, 2610, Antwerp, Belgium.

Publikováno v: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2023 Aug; Vol. 24 (6), pp. 909-922. Date of Electronic Publication: 2022 Sep 22.

Barriers and facilitators of appropriate antibiotic use in primary care institutions after an antibiotic quality improvement program - a nested qualitative study.

Autor: Harbin NJ; Antibiotic Center for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Postboks 1130 Blindern, 0317, Oslo, Norway. n.j.harbin@medisin.uio.no., Lindbæk M; Antibiotic Center for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Postboks 1130 Blindern, 0317, Oslo, Norway., Romøren M; Centre for Medical Ethics, Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.

Publikováno v: BMC geriatrics [BMC Geriatr] 2022 May 27; Vol. 22 (1), pp. 458. Date of Electronic Publication: 2022 May 27.

Erratum to: Oral and parenteral antibiotic use in Norwegian nursing homes: are primary care institutions becoming our new local hospitals?

Autor: Harbin NJ, Haug JB, Romøren M, Lindbæk M

Publikováno v: JAC-antimicrobial resistance [JAC Antimicrob Resist] 2022 Feb 09; Vol. 4 (1), pp. dlac010. Date of Electronic Publication: 2022 Feb 09 (Print Publication: 2022).

Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC ⁴ E Trial.

Autor: Li X; Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium. xiao.li@uantwerpen.be., Bilcke J; Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium., van der Velden AW; Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands., Bongard E; The Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Bruyndonckx R; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute (DSI), Hasselt University, Hasselt, Belgium.; Department of Family Medicine and Population Health (FAMPOP), Vaccine and Infectious Disease Institute (VAXINFECTIO), Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium., Sundvall PD; Primary Health Care, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Research and Development Primary Health Care Region Västra Götaland, Research and Development Centre Södra Älvsborg, Borås, Sweden., Harbin NJ; Antibiotic Center for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway., Coenen S; Department of Family Medicine and Population Health (FAMPOP), Vaccine and Infectious Disease Institute (VAXINFECTIO), Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium., Francis N; School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK., Bruno P; Département de Santé Publique, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France., Garcia-Sangenis A; Drug Study Unit, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain., Glinz D; Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland., Kosiek K; Family Doctors' Clinic, Lodz, Poland., Mikó-Pauer R; DRC Drug Research Center LLC, Balatonfüred, Hungary., Radzeviciene Jurgute R; FDC Mano šeimos gydytojas, Klaipeda, Lithuania., Seifert B; First Faculty of Medicine, Institute of General Practice, Charles University in Prague, Prague, Czech Republic., Tsakountakis N; Malia Surgery, Kastelli HC, Heraklio, Greece., Aabenhus R; Section and Research Unit of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Butler CC; The Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Beutels P; Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium.

Publikováno v: Clinical drug investigation [Clin Drug Investig] 2021 Aug; Vol. 41 (8), pp. 685-699. Date of Electronic Publication: 2021 Jul 22.